These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37972684)

  • 1. Distribution, connection and function of ALDH1A1
    Liu H; Gong Z; Li Z; Ye T; Cao A; He S; Lin S; Duan J; Lin X
    Neurosci Lett; 2024 Jan; 818():137555. PubMed ID: 37972684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting parvalbumin-expressing neurons in the substantia nigra pars reticulata restores motor function in parkinsonian mice.
    Delgado-Zabalza L; Mallet NP; Glangetas C; Dabee G; Garret M; Miguelez C; Baufreton J
    Cell Rep; 2023 Oct; 42(10):113287. PubMed ID: 37843977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia.
    Hu Y; Ma TC; Alberico SL; Ding Y; Jin L; Kang UJ
    Mov Disord; 2023 Oct; 38(10):1850-1860. PubMed ID: 37461292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson's disease.
    Moore C; Xu M; Bohlen JK; Meshul CK
    Eur J Neurosci; 2021 Apr; 53(7):2061-2077. PubMed ID: 32619030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism.
    Sitzia G; Mantas I; Zhang X; Svenningsson P; Chergui K
    Neuropharmacology; 2020 Sep; 174():108136. PubMed ID: 32474027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson's disease model.
    Del Rey NL; Hernández-Pinedo N; Carrillo M; Del Cerro M; Esteban-García N; Trigo-Damas I; Monje MHG; Lanciego JL; Cavada C; Obeso JA; Blesa J
    NPJ Parkinsons Dis; 2024 Sep; 10(1):165. PubMed ID: 39223183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
    Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
    Sarabi A; Hoffer BJ; Olson L; Morales M
    J Comp Neurol; 2001 Dec; 441(2):106-17. PubMed ID: 11745638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
    Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
    J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons.
    Gouty S; Brown JM; Rosenberger J; Cox BM
    Neuroscience; 2010 Aug; 169(1):269-78. PubMed ID: 20417255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.
    Suárez F; Zhao Q; Monaghan DT; Jane DE; Jones S; Gibb AJ
    Eur J Neurosci; 2010 Aug; 32(3):359-67. PubMed ID: 20618827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory drive from the Subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids.
    Freestone PS; Wu XH; de Guzman G; Lipski J
    Eur J Pharmacol; 2015 Nov; 767():144-51. PubMed ID: 26472124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
    Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
    Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen and glucose deprivation (OGD)-induced spreading depression in the Substantia Nigra.
    Karunasinghe RN; Lipski J
    Brain Res; 2013 Aug; 1527():209-21. PubMed ID: 23796781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT
    Ishii T; Kinoshita KI; Muroi Y
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
    Cáceres-Chávez VA; Hernández-Martínez R; Pérez-Ortega J; Herrera-Valdez MA; Aceves JJ; Galarraga E; Bargas J
    J Neurophysiol; 2018 Dec; 120(6):2922-2938. PubMed ID: 30256736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.